About Putative ATP-dependent DNA helicase DDX12
Putative ATP-dependent DNA helicase DDX12 (DDX12P) is a protein
from Homo sapiens identified by UniProt accession
Q92771, 950 residues long.
MolForge cross-references it against 0 known binders and
0 disease associations.
Target properties
| Protein name | Putative ATP-dependent DNA helicase DDX12 |
|---|
| UniProt accession | Q92771 |
|---|
| Gene | DDX12P |
|---|
| Organism | Homo sapiens |
|---|
| Length | 950 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q92771-F1 | alphafold | PREDICTED | 76.21 | — |
Amino-acid sequence (950 residues)
MRSGGGCSGS LSLRGPASFK FSGVCPDSRG LAFSVAILPA KKEDFMAELY RVLEAGKIGI FESPTGTGKS LSLICGALSW LRDFEQKKRE EEARLLETGT GPLHDEKDES LCLSSSCEGA AGTPRPAGEP AWVTQFVQKK EERDLVNRLK AEQARRKQRE ERLQQLQHRV QLKYAAKRLR QEEEERENLL RLSREMLETG PEAERPEQLE SGEEELVLAE YESDEEKKVA SGVDEDEDDL EEEHITKIYH CSRTHSQLAQ FVHEVKKSPF GKDVRLVSLG SRQNLCVNED VRSLGSVQLI NNRCVDMQRS RHEKKKGAEE EKPKRRRQEK QAACPFYNHE QMGLLRDEAL AEVKDMEQLL ALGKEARACP YYGSRLAIPA AQLVVLPYQM LLHAATRQAA GIRLQDQVVI IDEAHNLIDT TTSMHSVEVS GSQLCQAHSQ LLQYMERYGK RLKAKNLMYL KQILYLLEKF VAVLGGNIKQ NPNTQSLSQT GMELKTINDF LFQSQIDNIN LFKVQRYCEK SMISRKLFGF TERYGAVFSS REQPKLAGFQ QFLQSLQPRT TEALAAPADE SQASVPQPAS PLMHIEGFLA ALTTANQDGR VILSRQGSLS QSTLKFLLLN PAVHFAQVVK ECRAVVIAGG TMQPVSNFRQ QLLACAGVEA ERVVEFSCGH VIPPDNILPL VICSGVSNQP LEFTFQKRDL PQMMDEVGRI LCNLCGVVSG GVVCFFPSYE YLRQVHAHWE KGGLLGRLAA RKKIFQEPKS AHQVEQVLLA YSRCLQACGQ ERGPVTGALL LSVVGGKMSE GINFSDNLGR CVVMVGMPFP NIRSAELQEK MAYLDQTLPR APGQAHPGKA LVENLCMKAV NQSIGRAIRH QKDFASIVLL DQRYARPPVL AKLPAWIRAR VEVKATFGPA IAAVQKVSPT FFFLRASQPR DHISHCLLSA QFHREKSASS
Explore Putative ATP-dependent DNA helicase DDX12 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets